Canetti/iStock via Getty Images I have chronicled the ups and downs of Dynavax (NASDAQ:DVAX) since 01/2017's "Dynavax In 2017: Hero Or Zero?. My most recent article was 03/2024's "Dynavax: Holding Firm Despite Its Missing Cash Cow" ("Holding Firm "). The premise of Holding Firm was, despite its cash cow CpG1018 being effectively off the table, it was fairly valued at its then market cap of $1.58 billion. As I write on 08/21/2024 its market cap has declined modestly to $1.49 billion. In this article, I will ...